Michael S. Weiss TG Therapeutics CEO Rating | Comparably
TG Therapeutics Claimed Company
TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval by several foreign nations for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. For more information, visit www.tgtherapeutics.com, and follow us on X (formerly Twitter) @TGTherapeutics and on LinkedIn. BRIUMVI® is a registered trademark of TG Therapeutics, Inc. read more
EMPLOYEE
PARTICIPANTS
31
TOTAL
RATINGS
639
HR or Marketing? Claim Your Free Employer Account

Michael S. Weiss TG Therapeutics' CEO
Michael S. Weiss TG Therapeutics CEO Rating

TG Therapeutics' CEO, Michael S. Weiss, has 31 employee ratings and a score of 85/100, placing them in the Top 5% of similar size companies on Comparably with 201-500 Employees. When breaking the CEO score down by factors such as department, gender, and ethnicity, we see that females at TG Therapeutics rate Michael S. Weiss higher than males, giving the CEO a score of 87/100.

Last updated 13 days ago.

Where This Score Ranks TG Therapeutics' CEO Rating

  • TOP
    5%

    In the Top 5% of 2013 Similar Sized Companies on Comparably

  • 1st

    1st place versus 3 competitors rated on Comparably

80
May
81
Jun
82
Jul
83
Sep
85
Oct
A+85 / 100
Nov

TG Therapeutics CEO Michael S. Weiss Bio

Michael S. Weiss has served as TG’s Chairman, President and CEO since December 2011. Mr. Weiss is also currently a director of the Company. From 2002 to 2009, Mr. Weiss was the Chairman and Chief Executive Officer of Keryx Biopharmaceuticals, Inc. Mr. Weiss began his professional career as a lawyer with Cravath, Swaine & Moore LLP. He earned his J.D. from Columbia Law School and his B.S. in Finance from The University at Albany. Based on Mr. Weiss’s biotechnology and pharmaceutical industry experience, as well as his extensive management experience, the Board believes that Mr. Weiss has the appropriate set of skills to serve as a member of the Board. Mr. Weiss also serves as a Director and Executive Vice Chairman of Fortress Biotech, Inc., and as Chairman of the board of directors of Mustang Bio, Inc. Additionally, Mr. Weiss co-founded and served as Co-Portfolio Manager and Managing Partner of Opus Point Partners, LLC from 2009 to 2019.

Who Ranks TG Therapeutics' CEO Rating the Highest?
Ethnicity - Hispanic or Latino 87/100
Gender - Female 87/100
Experience - 3 to 6 Years 73/100
Who Ranks TG Therapeutics' CEO Rating the Lowest?
Gender - Male 48/100
Experience - 1 to 3 Years 68/100
Ethnicity - Caucasian 72/100

TG Therapeutics CEO Michael S. Weiss At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at TG Therapeutics.

Based on 31 ratings, Michael S. Weiss ranks right above Biogen's CEO, Michel Vounatsos.

TG Therapeutics' CEO is highly regarded by Hispanic or Latino employees, Female employees, and employees with 3 to 6 Years experience. However, Male employees, employees with 1 to 3 Years experience, and Caucasian employees have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.

TG Therapeutics CEO Michael S. Weiss Rating Trendline

  • TG Therapeutics85
  • Similar Size on Comparably

How TG Therapeutics' CEO Rating Score is Calculated

FILTER RATINGS BY

Results from 29 Employees in All Departments, All Genders, All Ethnicities and All Yrs. Experience Experience

85
out of 100
How would you rate your CEO?

TG Therapeutics' CEO Rating Rank Against Similar Sized Companies on Comparably

TOP
5%

TG Therapeutics ranks in the Top 5% of other companies on Comparably with 201-500 Employees for CEO Rating Score.

  1. Crumbs Bake Shop
    85 / 100
  2. Riverside Research
    85 / 100
  3. RAPP
    85 / 100
  4. TG Therapeutics
    85 / 100
  5. HomeLight
    84 / 100
  6. Avant
    84 / 100
  7. B & B Manufacturing
    84 / 100

Anonymously Ask TG Therapeutics Any Question

Your questions will be posted publicly. Please don't submit any personal information.

×
Rate your company